Literature DB >> 1663253

Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor.

M J Picker1, J Yarbrough.   

Abstract

The purpose of the present experiment was to determine whether the effects of opioids with varying degrees of efficacy at the mu receptor are differentially altered in morphine-tolerant pigeons. To this end, dose-effect curves were determined for high, intermediate, and low efficacy mu agonists in pigeons responding under a schedule of food presentation prior to, during, and after exposure to a regimen of chronic morphine administration. In pigeons treated with 56 mg/kg/daily morphine, the dose-effect curves for the rate-decreasing effects of the high-efficacy mu agonists morphine and fentanyl were shifted to the right of their prechronic positions (i.e., tolerance). A small degree of tolerance was also conferred to the intermediate-efficacy mu agonists (-)-pentazocine and (-)-metazocine, but not to nalbuphine or butorphanol. In contrast to the effects obtained with these mu agonists, the chronic morphine regimen shifted the dose-effects curves of the mu antagonist naloxone and the low-efficacy mu agonists nalorphine and levallorphan to the left of their prechronic positions (i.e., enhanced sensitivity). These findings demonstrate that morphine tolerance confers cross-tolerance to other high efficacy mu agonists, enhanced sensitivity to mu antagonists and low efficacy mu agonists, and little or no cross-tolerance to intermediate efficacy mu agonists. Disadvantages of using schedule-controlled responding to examine the effects of intermediate efficacy mu agonists are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663253     DOI: 10.1007/bf02244364

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol.

Authors:  J M O'Donnell
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

2.  History and development of mixed opioid agonists, partial agonists and antagonists.

Authors:  W R Martin
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.

Authors:  J Magnan; S J Paterson; A Tavani; H W Kosterlitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

Review 4.  Nalbuphine.

Authors:  W K Schmidt; S W Tam; G S Shotzberger; D H Smith; R Clark; V G Vernier
Journal:  Drug Alcohol Depend       Date:  1985-02       Impact factor: 4.492

5.  Discriminative stimulus effects of naltrexone in the morphine-dependent rat.

Authors:  V F Gellert; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

6.  Chronic administration of S-(-)-pentobarbital in pigeons and rats: tolerance development.

Authors:  G R Wenger
Journal:  Pharmacol Biochem Behav       Date:  1988-10       Impact factor: 3.533

7.  Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.

Authors:  G T Shearman; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  The contribution of intrinsic activity to the action of opioids in vitro.

Authors:  L Miller; J S Shaw; E M Whiting
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

9.  Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation.

Authors:  A H Oliveto; M J Picker; L A Dykstra
Journal:  J Pharmacol Exp Ther       Date:  1991-04       Impact factor: 4.030

10.  Opioid agonists/antagonists in morphine-tolerant squirrel monkeys.

Authors:  L A Dykstra; M J Picker; K R Powell
Journal:  Pharmacol Biochem Behav       Date:  1990-07       Impact factor: 3.533

View more
  2 in total

1.  Abuse-related effects of µ-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure.

Authors:  Ahmad A Altarifi; Kenner C Rice; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

2.  Enhancement of Opioid Antinociception by Nicotine.

Authors:  Fernando Barreto de Moura; Sarah Louise Withey; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2019-09-16       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.